Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis

Multiple Sclerosis Journal

Volumn 18, Issue 1, 2012, Pages 45-54

  Cossburn, M ^a   Ingram, G ^a   Hirst, C ^a   Ben Shlomo, Y ^b   Pickersgill, T P ^a   Robertson, N P ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

aging; epidemiology; multiple sclerosis; natural history

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; PHENOTYPE; PROSPECTIVE STUDY; RELAPSE; REMISSION; SEX DIFFERENCE;

EID: 84855919889     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511417479     Document Type: Article

References (42)

1. Compston A, Coles A. Multiple sclerosis. Lancet. 2002 ; 359: 1221-1231 (Pubitemid 34304266)
2. Bronnum-Hansen K, Hyllsted K. Survival of patient with multiple sclerosis in Denmark: a nationwide, long-term epidemiologic study. Neurology. 1994 ; 44: 1901-1907
3. Weinshenker B, Rice G, Noseworthy J, Carriere W, Baskerville J, Ebers G. The natural history of multiple scelrosis: qa geographically based study I: Clinical course and disability. Brain. 1989 ; 112: 133-146 (Pubitemid 19056478)
4. Lublin F, Reingold S. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) advisory committee on clinical trials of new agents in multiple sclerosis. Neurology. 1996 ; 46: 907-911
5. Hawkins SA, McDonnell GV. Benign multiple sclerosis? Clinical course, long-term follow-up and assessment of prognostic factors. J Neurol Neurosurg Psychiatry. 1999 ; 67: 148-152 (Pubitemid 29326942)
6. Miller D, Barkhof F, Montalban X, Thompson A, Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis, part 1 natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol. 2005 ; 4: 281-288 (Pubitemid 40545039)
7. Thompson AJ, Hutchinson M, Brazil J, Feighery C, Martin E. A clinical and laboratory study of benign multiple sclerosis. Q J Med. 1986 ; 58: 69-80 (Pubitemid 16101943)
8. Achiron A, Barak Y. Multiple sclerosis-from probable to definite diagnosis: a 7-year prospective study. Arch Neurol. 2000 ; 57: 974-979 (Pubitemid 30452502)
9. Boiko A, Vorobeychik G, Paty D, Devonshire V, Sadovnick D. Early onset multiple sclerosis: a longitudinal study. Neurology. 2002 ; 59: 1006-1010
10. Confavreux C, Vukusic S. Age at disability milestones in multiple sclerosis. Brain. 2006 ; 129: 595-605 (Pubitemid 43278222)
11. Renoux C, Vukusic S, Confavreux C. The natural history of multiple sclerosis with childhood onset. Clin Neurol Neurosurg. 2008 ; 110: 897-904
12. Harding AE, Sweeney MG, Miller DH, Mumford CJ, Kellar-Wood H, Menard D, et al. Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain. 1992 ; 115: 979-989
13. Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain. 2007 ; 130: 1194-1205 (Pubitemid 47355941)
14. WAG. Welsh Assembly Government Data For South-East Wales http://wales.gov.uk/location/south-east-wales/?lang=en (2008, accessed March 2011).
15. Hirst CL, Ingram G, Pickersgill TP, Swingler RJ, Compston DA, Robertson NP. Increasing prevalence and incidence of multiple sclerosis in South East Wales. J Neurol Neurosurg Psychiatry. 2009 ; 80: 386-391
16. Swingler RJ, Compston DA. The prevalence of multiple sclerosis in South East Wales. J Neurol Neurosurg Psychiatry. 1988 ; 51: 1520-1524 (Pubitemid 19026523)
17. Poser CM. Clinical diagnostic criteria in epidemiological studies of multiple sclerosis. Ann N Y Acad Sci. 1965 ; 122: 506-519
18. Poser CM. Diagnostic criteria for multiple sclerosis: an addendum. Ann Neurol. 1987 ; 22: 773
19. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001 ; 50: 121-127
20. Poser CM. Revisions to the 2001 McDonald diagnostic criteria. Ann Neurol. 2006 ; 59: 727-728
21. Confavreux C, Compston DA, Hommes OR, McDonald WI, Thompson AJ. EDMUS, a European database for multiple sclerosis. J Neurol Neurosurg Psychiatry. 1992 ; 55: 671-676
22. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology. 33: 1444-1452
23. Krupp LB, Banwell B, Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology. 2007 ; 68: S7 - S12
24. Global Consultation on Adolescent Health Services: A Consensus Statement. Geneva: WHO ; 2001:
25. Kis B, Rumberg B, Berlit P. Clinical characteristics of patients with late-onset multiple sclerosis. J Neurol. 2008 ; 255: 697-702
26. Martinelli V, Rodegher M, Moiola L, Comi G. Late-onset multiple sclerosis: clinical characteristics, prognostic factors and differential diagnosis. Neurol Sci. 2004 ; 25: S350 - S355
27. Robertson N, Deans J, Fraser M, Compston DA. Multiple sclerosis in the north Cambridgeshire districts of East Anglia. J Neurol Neurosurg Psychiatry. 1995 ; 59: 71-76
28. Confavreux C, Vukusic S. Natural history of multiple sclerosis: a unifying concept. Brain. 2006 ; 129: 606-616 (Pubitemid 43278223)
29. Koch-Henriksen N. An epidemiological study of multiple sclerosis. Familial aggregation social determinants, and exogenic factors. Acta Neurol Scand Suppl. 1989 ; 124: 1-123
30. Koch M, Mostert J, Heersema D, De Keyser J. Progression in multiple sclerosis: further evidence of an age-dependent process. J Neurol Sci. 2007 ; 255: 35-41 (Pubitemid 46414019)
31. Runmarker B, Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain. 1993 ; 116: 117-134 (Pubitemid 23087038)
32. Clark VA, Detels R, Visscher BR, Valdiviezo NL, Malmgren RM, Dudley JP. Factors associated with a malignant or benign course of multiple sclerosis. JAMA. 1982 ; 248: 856-860 (Pubitemid 12041485)
33. Leone MA, Bonissoni S, Collimedaglia L, Tesser F, Calzoni S, Stecco A, et al. Factors predicting incomplete recovery from relapses in multiple sclerosis: a prospective study. Mult Scler. 2008 ; 14: 485-493 (Pubitemid 351943861)
34. West T, Wyatt M, High A, Bostrom A, Waubant E. Are initial demyelinating event recovery and time to second event under differential control?. Neurology. 2006 ; 67: 809-813 (Pubitemid 44394194)
35. Gauthier SA, Mandel M, Guttmann CR, Glanz BI, Khoury SJ, Betensky RA, et al. Predicting short-term disability in multiple sclerosis. Neurology. 2007 ; 68: 2059-2065 (Pubitemid 46912123)
36. Confavreux C, Vukusic S, Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain. 2003 ; 126: 770-782 (Pubitemid 36372978)
37. Bergamaschi R, Quaglini S, Trojano M, Amato MP, Tavazzi E, Paolicelli D, et al. Early prediction of the long term evolution of multiple sclerosis: the Bayesian Risk Estimate for Multiple Sclerosis (BREMS) score. J Neurol Neurosurg Psychiatry. 2007 ; 78: 757-759 (Pubitemid 46998854)
38. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med. 2000 ; 343: 1430-1438
39. Mandrioli J, Sola P, Bedin R, Gambini M, Merelli E. A multifactorial prognostic index in multiple sclerosis. Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease. J Neurol. 2008 ; 255: 1023-1031
40. Debouverie M, Pittion-Vouyovitch S, Louis S, Guillemin F. Natural history of multiple sclerosis in a population-based cohort. Eur J Neurol. 2008 ; 15: 916-921
41. Orton SM, Herrera BM, Yee IM, Valdar W, Ramagopalan SV, Sadovnick AD, et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol. 2006 ; 5: 932-936 (Pubitemid 44556546)
42. Minneboo A, Jasperse B, Barkhof F, Uitdehaag BM, Knol DL, de Groot V, et al. Predicting short-term disability progression in early multiple sclerosis: added value of MRI parameters. J Neurol Neurosurg Psychiatry. 2008 ; 79: 917-923